GLP-1 Receptor Agonists: Clinical Evidence and Uses
GLP-1 Clinical Relevance #52Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical OverviewSystematic ReviewType 2 DiabetesGLP-1 Receptor AgonistPrimary…
Modulating the endocannabinoid system in alcohol use disorder: A translational systematic …
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchMental HealthAnxietyNeurologySafetyPolicyDosing Why This Matters I don't see a summary provided for…
TPS Cannabis News – StratCann
✦ New CED Clinical Relevance #85 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. I cannot complete this task as requested because you have not provided the actual cannabis news article content.…
Cannabis Use Disorder Strongly Linked to Major Depression, New Review Finds
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchTHCCannabis Use DisorderDepressionSafetyNeurology Why This Matters Clinicians treating patients…
GLP-1 Receptor Agonists and Hair Loss: Clinical Evidence
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical ReviewSystematic ReviewHair Loss and AlopeciaSemaglutideEndocrinologyAdults with ObesityAdverse…
GLP-1 Weight Loss Drugs: Clinical Evidence Guide
GLP-1 Clinical Relevance #52Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical ReviewSystematic ReviewWeight LossGLP-1 Receptor AgonistFamily MedicineAdults…
Efficacy of pharmacological treatments for Dravet syndrome: Systematic review and network …
✦ New CED Clinical Relevance #85 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyCBDPediatricsSafety Why This Matters This systematic review and network meta-analysis provides…
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data interpretation and the…
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data interpretation and the…
From Analgesia to Synaptic Remodeling: A Systematic Review of Acetaminophen’s Neuromodulatory Effects.
Neuro-related disorders will be rising globally. Current treatments have numerous limitations that can impair patients' quality of life. One of the key thera...